The GMPC and the editorial board of the German Journal of Veterinary Research are honored with joining of Prof. Adel Talaat, professor of Microbiology, University of Wisconsin-Madison, WI, USA as Section Editor for Veterinary Microbiology, and Infectious Diseases. D. Talaat is a pioneering microbiologist with a long-term interest in better understanding the pathogenesis of emerging infectious diseases. He received his veterinary and master degrees from Cairo University, Egypt, and Ph.D. from the School of Medicine, University of Maryland, Baltimore, USA. Currently, D. Talaat is a Professor of Microbiology at the University of Wisconsin-Madison.

D. Talaat research involves developing new technologies and innovative approaches to understand bacterial pathogenesis and to generate useful therapies (drugs and vaccines). Currently, D. Talaat research group is working on the functional genomics of Mycobacterium tuberculosis that infects humans and M. avium subsp. paratuberculosis that infects animals. Recently, D. Talaat started to utilize nanotechnology to develop nanovaccines to control human and animal infections, including avian viral agents such as avian influenza and coronavirus.  This innovative vaccine portfolio includes vaccines against Johnes disease for cattle and small ruminants as well as avian influenza and infectious bronchitis virus for poultry.

In 2011, D. Talaat started a biotechnology company (Pan Genome Systems, INC.) to further develop intellectual properties generated by the research group (vaccine-based patents) into products useful to improve human and animal health.